FDA Removes Testosterone Heart Risk Warning

For a decade, the FDA claimed testosterone increased the risk of heart attack, stroke, and major cardiac events… even slapping a black box warning (the strongest warning the FDA issues, typically reserved for life-threatening risks) on every testosterone product.

But now? They’re finally admitting they were wrong.

Last week, the FDA officially removed this warning in a class-wide labeling update for all testosterone products.

Their decision was based on new data from the TRAVERSE trial, a large, randomized, double-blind, placebo-controlled study that proved what we’ve known all along:

• Testosterone replacement therapy (TRT) does NOT increase cardiovascular risk
• It can reduce the risk of heart attack, stroke, and even death by 30% or more
• Millions of men were denied access to TRT due to outdated and flawed research

So how did the FDA get it so wrong in the first place?

It started with two deeply flawed studies (The Vegan Study & The Finkel Study)... both based on bad data, statistical manipulation, and zero control groups.

But now, after ignoring dozens of better studies for years, the FDA has finally reversed course.

In my latest YouTube video... I break it all down:

• The full story of the FDA’s mistake and reversal
• The real science proving TRT is safe and life-changing
• How testosterone therapy supports longevity, vitality, and overall well-being

It’s time to clear up the misinformation and take back control of your health.

Stay informed,

Tracy Gapin, MD

P.S. TRT improves quality of life, extends longevity, and protects your heart. If you’ve been hesitant about testosterone, now is the time to reconsider. Check out the video now!